Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. May 28, 2015; 21(20): 6271-6279
Published online May 28, 2015. doi: 10.3748/wjg.v21.i20.6271
Table 1 Correlation between NADPH oxidase 2 expression and clinical-pathological characters in gastric cancer n (%)
Clinical featureTotal number (n = 123)NOX2 positivity negativityχ2-valueP-value
Gender
Male6930 (43.5)0.8520.229
39 (56.5)
Female5428 (51.9)
26 (48.1)
Age (yr)
< 595527 (49.1)0.1500.419
28 (50.9)
≥ 596831 (45.6)
37 (54.4)
Position
Cardia and fundus308 (26.6)6.6830.008
22 (73.3)
Body and antrum9350 (53.8)
43 (46.2)
Differentiation type
High226 (27.3)5.0620.042
16 (72.7)
Moderate3416 (47.1)
18 (52.9)
Poor6234 (54.8)
28 (45.2)
Undifferentiation52 (40)
3 (60)
Lymph node metastasis
Yes5334 (64.2)10.7960.001
19 (35.8)
No7024 (34.3)
46 (65.7)
Vascular invasion
Yes6035 (58.3)5.8750.012
25 (41.7)
No6323 (36.5)
40 (63.5)
Clinical stage
Early stage329(28.1)6.2850.010
23(71.9)
Advanced stage9149(53.8)
42(46.2)
TNM
I + II3510(28.6)6.7790.008
25(71.4)
III + IV8848(68.6)
40(31.4)